TheEdgeResearch
Home / Stocks / SNNC

Sibannac, Inc. (SNNC)

OTC Healthcare Medical - Pharmaceuticals
$0.01 ▲ +0.00%
Market Cap
$253,175
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
1.64
52-Wk Range
0.004-0.0226
CEO
David A. Mersky
Country
US
Currency
USD

Sibannac, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Phoenix, AZ, US. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $253,175. On trailing twelve-month figures it carries a trailing P/E of -3.42, a net margin of -5323.7%. Its beta of 1.64 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.42
Price / Sales
46.03
Price / Book
-1.69
EV / EBITDA
-2.64
Gross margin
-27.7%
Operating margin
-4896.6%
Net margin
-5323.7%
Return on equity
Debt / equity
-0.70
Current ratio
0.05
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2014-02-10
Headquarters
Phoenix, AZ, US
About Sibannac, Inc.

Sibannac, Inc. operates as a media and management services company. It serves businesses with online marketing, advertising, sales tracking, management consulting, and other informational services. The company also provides accounting, and expense and labor management systems to assist in compliance in the regulated industry environment. Sibannac, Inc. is based in Phoenix, Arizona.

Comparable companies

Sibannac, Inc. is most often compared with the following Healthcare names:

CNNXFCSTFERBBGBHPFGRVEINSOLVTTFMGWFFSKYISTSN
More research on SNNC
SNNC technical analysis SNNC TheEdge Score Compare against peers
Open full interactive analysis & DCF →